Dermatology physicians and advanced practice providers who care for patients with moderate to severe atopic dermatitis within inner city communities
Upon completion of this activity, participants should be able to:
Identify potential healthcare disparities impacting patients in inner-city communities with moderate to severe atopic dermatitis
Incorporate strategies that are aimed at providing optimal management of moderate to severe atopic dermatitis to patients impacted by healthcare disparities in inner-city communities
Clinical Care Options, LLC (CCO) and Partners for Advancing Clinical Education (PACE) require instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO and PACE policy. CCO and PACE are committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.
The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity:
Heather Woolery-Lloyd, MD: consultant/speaker/advisor: Allergan, Arcutis, Bausch + Lomb, Eirion Therapeutics, Galderma, Incyte, Johnson & Johnson, Lilly, Merz, Ortho Dermatologics, Pfizer, Sanofi.
Leighanne McGill, PA-C, has no relevant financial relationships to disclose.
The planners and content peer reviewers from Partners for Advancing Clinical Education, Clinical Care Options, LLC, and Practicing Clinicians Exchange do not have any relevant financial relationships to disclose.
Participation in this self-study activity should be completed in approximately 0.5 hours. To successfully complete this activity and receive credit, learners must follow these steps during the period from March 09, 2023, through March 08, 2024:
You must receive a test score of at least 65% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by clicking the certificate link on the confirmation page. Records of all CME/CE activities completed can be found on the "My Certificates" page. There are no costs/fees for this activity.
The program has been made available online
The opinions or views expressed in this CE/CME activity do not necessarily reflect the opinions or recommendations of Partners for Advancing Clinical Education, Clinical Care Options, LLC, Practicing Clinicians Exchange, or any educational supporter.
Joint Accreditation Statement
In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Physician Continuing Medical Education
CCO designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Joint Accreditation Statement
In support of improving patient care, Partners for Advancing Clinical Education (PACE) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team
ANCC Credit Designation
The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 0.50 contact hours.
AAPA Credit Designation
Partners for Advancing Clinical Education (PACE) has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.5 AAPA Category 1 CME credits. Approval is valid until March 08, 2024. PAs should only claim credit commensurate with the extent of their participation.